The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2022

Filed:

May. 14, 2020
Applicant:

Temple University of the Commonwealth System of Higher Education, Philadelphia, PA (US);

Inventors:

Kamel Khalili, Bala Cynwyd, PA (US);

Wenhui Hu, Cherry Hill, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); C12N 15/11 (2006.01); A61K 48/00 (2006.01); A61K 9/00 (2006.01); A61K 35/12 (2015.01); A61K 45/06 (2006.01); C12N 7/00 (2006.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A61K 9/0034 (2013.01); A61K 35/12 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); A61K 48/005 (2013.01); C12N 7/00 (2013.01); C12N 9/22 (2013.01); C12N 15/111 (2013.01); C12N 2310/20 (2017.05); C12N 2320/30 (2013.01); C12N 2740/16063 (2013.01); C12Y 301/21 (2013.01);
Abstract

A method of preventing transmission of a retrovirus from a mother to her offspring, by administering to the mother a therapeutically effective amount of a composition comprising a Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-associated endonuclease, and the two or more different multiplex gRNAs, wherein each of the at least two gRNAs is complementary to a different target nucleic acid sequence in a long terminal repeat (LTR) of proviral DNA of the virus that is unique from the genome of the host cell, cleaving a double strand of the proviral DNA at a first target protospacer sequence with the CRISPR-associated endonuclease, cleaving a double strand of the proviral DNA at a second target protospacer sequence with the CRISPR-associated endonuclease, excising an entire HIV-1 proviral genome, eradicating the HIV-1 proviral DNA from the host cell, and preventing transmission of the proviral DNA to the offspring.


Find Patent Forward Citations

Loading…